New Republic Capital’s Medtronic MDT Stock Holding History

New Republic Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,321	Closed	-$203K	–	369
2026 Q1	$203K	Sell	2,321 -1,550	-40%	-$148K	0.07%	235
2025 Q4	$375K	Buy	3,871 +1,755	+83%	+$170K	0.1%	183
2025 Q3	$201K	Buy	+2,116	New	+$195K	0.06%	191
2024 Q1	–	Sell	-3,134	Closed	-$260K	–	234
2023 Q4	$260K	Buy	+3,134	New	+$239K	0.19%	126
2023 Q3	–	Sell	-2,607	Closed	-$231K	–	236
2023 Q2	$231K	Buy	+2,607	New	+$224K	0.16%	122

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

New Republic Capital's MDT Position: Q2 2026 in Review

New Republic Capital sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,321 shares — an estimated $203K sold.

New Republic Capital first reported a position in MDT in Q2 2023 and held it in 5 quarters. The position peaked at $375K in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

New Republic Capital reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
New Republic Capital sold 2,321 Medtronic shares in Q2 2026, an estimated $203K.
New Republic Capital first reported a position in Medtronic in Q2 2023 and held it in 5 quarters.
New Republic Capital's Medtronic position peaked at $375K in Q4 2025.
2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.